24,31,36 We adjusted drug-regimen based on NAC-pharmacokinetics, safety and efficacy, and severity of IPTB, and maintained treatment until delivery
Clinicians who use the agents associated with significant weight loss, should be aware of concerns about associated loss of muscle function
Available from: Tandvrds- och lkemedelsfrmnsverket (TLV) (2022) Olika typer av subvention - Tandvrds- och lkemedelsfrmnsverket TLV
A patient scenario we hadn't anticipated
This guide provides a clear, evidence-based overview of how semaglutide (Wegovy) supports sustainable weight loss, including who qualifies, how dosing works, and how to manage side effects safely